Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion type Assertion NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_head.
- NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion description "[We conducted a pilot clinical trial testing a `third-generation` CD20-specific CAR with CD28 and 4-1BB costimulatory domains in patients with relapsed indolent B-cell and mantle cell lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_provenance.
- NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion evidence source_evidence_literature NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_provenance.
- NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion SIO_000772 22308288 NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_provenance.
- NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion wasDerivedFrom befree-20140225 NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_provenance.
- NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_assertion wasGeneratedBy ECO_0000203 NP433903.RAmjQFXKcHV97w1YxsQnfMnj2foIVDNrlWZjHGEcqhSu4130_provenance.